Address: 780 Cailun Road, Suite 802 Pudong, Shanghai 201203 P.R. China
HUYA Bioscience has developed an innovative approach – the HUYA Integrated Co-development Model – for partnering with Chinese research institutions and pharmaceutical companies to bring promising novel compounds into the Western development process and biopharma market.
HUYA searches for and targets drug compounds that have already demonstrated promising results within China’s SFDA (State Food and Drug Administration, China) testing program and provides a bridge to Western pharmaceutical partners. The data gathered from the SFDA testing provides invaluable guidance regarding the best methods and procedures for FDA and EMEA submissions in the West. Because the compounds have been rigorously evaluated and validated in China, Western partners benefit from streamlined development, lower costs, and greatly reduced risk.
Products and services
early stage compounds